First ever FDA-approved brain-computer interface targets stroke rehab

Good News Notes:

“A novel device designed to help stroke patients recover wrist and hand function has been approved by the US Food and Drug Administration (FDA). Called IpsiHand, the system is the first brain-computer interface (BCI) device to ever receive FDA market approval.

The IpsiHand device consists of two separate parts – a wireless exoskeleton that is positioned over the wrist, and a small headpiece that records brain activity using non-invasive electroencephalography (EEG) electrodes. The system is based on a discovery made by Eric Leuthardt and colleagues at the Washington University School of Medicine over a decade ago.

It is well known that each side of the brain controls movement on the opposite side of the body, so if a stroke damages motor function on the right side of the brain movement on a person’s left side will be affected.

Leuthardt and his team’s discovery back in 2008 revealed signals for body movement can be detected on the same side of the brain, but these signals are futile when the opposite side of the brain, which is actually responsible for executing the movement, is damaged. This specific brain activity was called ipsilateral brain signals.

The idea behind the novel BCI device was to find a way to detect those ipsilateral signals and use them to control an electronic hand brace. In 2017 the researchers demonstrated how patients using the device for 12 weeks, in the context of rehabilitation, significantly improved some degree of motor function by essentially retraining their brain to communicate with their hand.

“Generally, any motor impairments experienced by a patient six months after a stroke have been considered permanent,” says Leuthardt, who co-founded a company called Neurolutions back in 2007 to commercialize this technology. “What we’ve found with this device is that many patients can get a meaningful improvement in recovery of upper extremity movement when we wouldn’t expect them to get any. That’s not really true for any of the current therapies for stroke aimed at restoring function after the initial recovery period….”

View the whole story here:

Leave a Reply